mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.3 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.3 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.3 |
mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.3 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.3 |
mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.3 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.3 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.3 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.3 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |